Medicus Pharma Ltd (NASDAQ:MDCX)’s traded shares stood at 0.36 million during the last session. At the close of trading, the stock’s price was $3.38, to imply an increase of 4.97% or $0.16 in intraday trading. The MDCX share’s 52-week high remains $8.94, putting it -164.5% down since that peak but still an impressive 46.75% since price per share fell to its 52-week low of $1.80. The company has a valuation of $53.86M, with an average of 0.31 million shares in intraday trading volume over the past 10 days and average of 250.70K shares over the past 3 months.
Medicus Pharma Ltd (NASDAQ:MDCX) trade information
After registering a 4.97% upside in the last session, Medicus Pharma Ltd (MDCX) has traded red over the past five days. The 5-day price performance for the stock is 9.03%, and 33.86% over 30 days. Short interest in Medicus Pharma Ltd (NASDAQ:MDCX) saw shorts transact 0.11 million shares and set a 0.25 days time to cover.
MDCX Dividends
Medicus Pharma Ltd has its next earnings report out on 2025-May-11. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Medicus Pharma Ltd (NASDAQ:MDCX)’s Major holders
Medicus Pharma Ltd insiders hold 44.95% of total outstanding shares, with institutional holders owning 19.20% of the shares at 34.88% float percentage. In total, 19.20% institutions holds shares in the company.
